EsoBiotec Begins Clinical Trial of In Vivo BCMA CAR-T Candidate ESO-T01 for Multiple Myeloma
ESO-T01 is the first in vivo BCMA CAR-T candidate to reach the clinical stageEarly clinical data are expected in second half of ...
Le Lézard11h
Expression Therapeutics Announces Promising Phase 1 Results for Groundbreaking Hemophilia A Gene Therapy at ASH
Expression Therapeutics, Inc., has presented the results of a Phase 1 clinical trial for its novel lentiviral vector-based gene therapy ? ET3 ? for hemophilia A at the Annual Meeting of the American ...
pharmaphorum5d
Viva in vivo: The next generation of cell therapy is fast approaching
A handful of biotechs are asking a next-generation question ... The companies all use modified versions of the same lentiviral vectors used in ex vivo CAR-T therapy. “We're using the same ...
eLife3d
Evolutionary and functional analyses reveal a role for the RHIM in tuning RIPK3 activity across vertebrates
By exploring the conservation and functional diversity of RIPK3 and related RHIM-containing proteins across vertebrates, this important work sheds light on the evolutionary dynamics of these key ...
Contract Pharma3d
Contract Manufacturing
As (bio)pharma companies continue to focus on their core competencies they continue to rely on contract manufacturing organizations (CMOs).